|
11 Aug 2010 |
Crucell and Harvard (BIDMC) Join Forces with IAVI to Advance AdVac(R)-based AIDS Vaccine
|
|
11 Aug 2010 |
Emergent BioSolutions and Temasek Life Sciences Ventures Establish Joint Venture to Develop Broad Spectrum Pandemic Flu Vaccine and Therapeutic
|
|
10 Aug 2010 |
Nabi Biopharmaceuticals Completes Third PentaStaph(TM) Milestone
|
|
04 Aug 2010 |
TapImmune Signs Research and Technology License Option Agreement for Smallpox Vaccine
|
|
03 Aug 2010 |
Long-Term Follow-Up of DCVax®-Treated Brain Cancer Patients Shows 33% of Patients Reached 4-Year Survival and 27% Have Reached or Exceeded 6-Year Survival
|
|
03 Aug 2010 |
Advaxis Gets Formal Go-Ahead from India's DCGI to Conduct Phase II Cervical Cancer Trial
|
|
02 Aug 2010 |
FDA Approves Vaccines for the 2010-2011 Influenza Season
|
|
28 Jul 2010 |
Oxford BioMedica Announces FDA Approval for TroVax Phase II Study in Prostate Cancer
|
|
28 Jul 2010 |
Etubics Enters Phase I Cancer Clinical Trials Focused on Colorectal Cancer
|
|
28 Jul 2010 |
Advaxis Phase I Survival Update
|
|
27 Jul 2010 |
Sinopharm and Merck Sign Statement of Mutual Intent
|
|
27 Jul 2010 |
Dynavax Completes Enrollment and First Immunizations in Universal Flu Vaccine Study
|
|
27 Jul 2010 |
Antigenics Presents Positive, Top Line Data from Phase I Herpes Clinical Trial
|
|
26 Jul 2010 |
FDA Grants Orphan Drug Status for Personalized Cancer Vaccine, BiovaxID, Targeting Mantle Cell Lymphoma
|
|
26 Jul 2010 |
Vical's Herpes Simplex Vaccines Protect Against Lethal Challenge and Demonstrate Significant Therapeutic Benefit in Animal Models
|
|
22 Jul 2010 |
MabVax Therapeutics Initiates Phase II Clinical Trial of Vaccine to Prevent Recurrent Sarcoma
|
|
19 Jul 2010 |
Immunacia's Genetic Immunity Reports Phase II Data on DermaVir, a Therapeutic Vaccine for HIV/AIDS, During the XVIII International AIDS Conference: A 70% Viral Load Reduction Demonstrated in HIV Drug-naïve Individuals
|
|
19 Jul 2010 |
Phase II Data from FIT Biotech's HIV Immunotherapy Show Reduction in Viral Load and Increase in CD4 Cell Count
|
|
19 Jul 2010 |
Argos Therapeutics' Arcelis HIV Immunotherapy Demonstrates Significant Reduction in Viral Load and Delay in Viral Rebound Kinetics in Interim Analysis of Phase 2 Study
|
|
16 Jul 2010 |
A*STAR & CYTOS BIOTECHNOLOGY ESTABLISH INFLUENZA VACCINE COLLABORATION
|
|
15 Jul 2010 |
PharmAthene Presents New Data for Lyophilized rPA Anthrax Vaccine Showing Enhanced Immunogenicity
|
|
15 Jul 2010 |
Aduro BioTech Announces Key Milestones in Advancing Its Leading Listeria-Based Immunotherapy Program
|
|
14 Jul 2010 |
Nabi Biopharmaceuticals Completes Enrollment of First NicVAX Phase III Clinical Trial
|
|
13 Jul 2010 |
Generex Oncology Granted United States Patent for AE37 Peptide Vaccine
|
|
12 Jul 2010 |
Immunovaccine Licenses Clinical Stage Cancer Vaccine from Merck KGaA
|
